- Lifeward (Nasdaq: LFWD) has enabled a paralyzed Israeli soldier to walk again using the ReWalk Personal Exoskeleton, marking a significant milestone in rehabilitation technology.
- The Israeli Ministry of Defense is evaluating the device for potential use with other paralyzed veterans, indicating a potential expansion into military healthcare.
- This case marks the first successful use of ReWalk among war casualties in Israel, setting the stage for broader adoption and formal approval.
Lifeward Ltd. (Nasdaq: LFWD), a leader in innovative medical technology, announced a breakthrough in rehabilitation for paralyzed individuals. A 25-year-old Israeli reserve combat soldier has become the first among war casualties to regain the ability to walk using the ReWalk Personal Exoskeleton. This achievement was accomplished through a comprehensive rehabilitation program at Beilinson Hospital under the supervision of Dr. Yaron Watts.
The soldier, paralyzed in both legs, successfully completed training and has since taken the exoskeleton home. This development represents a critical clinical milestone, as it demonstrates the system's capacity to restore mobility for those with complete lower-limb paralysis. Dr. Watts described the event as a "precedent-setting historic event," advocating for the system's recognition by the Ministry of Defense's Rehabilitation Department, similar to the provision of smart prosthetics to amputees.
Following this success, the Israeli Rehabilitation Department is evaluating the safety and efficacy of the ReWalk system for wider implementation among other paralyzed veterans. This evaluation could pave the way for institutional adoption and standardization within military medical programs.
"We are proud to provide an exoskeleton that transforms lives," said Larry Jasinski, CEO of Lifeward. He emphasized the company's commitment to expanding access to the ReWalk exoskeleton for eligible users, particularly injured armed forces personnel.
